Outcomes of Allogeneic or Autologous Stem Cell Transplantation Followed by Maintenance Chemotherapy in Adult Patient With B-ALL in CR1 With No Detectable Minimal Residual Disease

Researchers retrospectively analyzed the outcomes of 355 adult patients with B cell acute lymphoblastic leukemia in first complete remission who had received auto-HSCT or allogeneic HSCT in their centre.